The nominal “Alzheimer’s disease” pathway is the foremost one identified by BioPlanet for the discriminant gene set for FDG-18, implicated via the influence of BACE2 and NDUFS4. This evidence concerns the gene BACE2 and early-onset autosomal dominant Alzheimer disease.